Acupuncture and Related Therapies for Endometriosis: A Network Meta-Analysis of Randomized Controlled Trials
Haiping Li,Xuesong Wang,Yu Wang,Yuanbo Gao,Xiaojun Zheng,Xifen Zhang,Xuxin Li,Xihui Zheng,Xisheng Fan,Guang Zuo,Yanfen She
DOI: https://doi.org/10.2147/jpr.s488343
IF: 2.8319
2024-10-02
Journal of Pain Research
Abstract:Haiping Li, 1, &ast Xuesong Wang, 1, &ast Yu Wang, 1 Yuanbo Gao, 1 Xiaojun Zheng, 1 Xifen Zhang, 1 Xuxin Li, 1 Xihui Zheng, 1 Xisheng Fan, 1, 2 Guang Zuo, 1 Yanfen She 1, 2 1 College of Acupuncture-Moxibustion and Tuina, Hebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, People's Republic of China; 2 Hebei International Joint Research Center for Dominant Diseases in Chinese Medicine and Acupuncture, Hebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Guang Zuo; Yanfen She, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Shijiazhuang City, Hebei Province, 050200, People's Republic of China, Email ; Background: Acupuncture and related therapies are effective and safe ways to relieve the pain, and improve the health and quality of life in women with endometriosis-related pain. However, it is still unclear which treatment is the most effective. Our study aims to summarize the evidence and determine the most effective and safe method to treat the endometriosis. Methods: We searched PubMed, EMBASE, Cochrane Library, and Web of science, China Biology Medicine, China National Knowledge Infrastructure, Wan fang Data, Chinese Scientific Journal Database and conducted manual searches of relevant papers, summarized randomized clinical trials of acupuncture-related therapies for endometriosis from database inception to 21 April 2024. After independent literature screening and data extraction that pain VAS was selected as the primary outcome measure. The quality evaluation was conducted by Review Manager 5.4. Perform network meta-analysis (NMA) used Stata 15.0 software. Results: Forty-two eligible trials involving six acupuncture-related interventions and 3,635 participants were included in this NMA. Pairwise meta-analyses show that combination therapy was more efficacious than western medicine and Chinese herb medicine for pain VAS scores, serum CA125 level and response rate results. The NMA estimates indicated that: for pain VAS scores, acupuncture (SMD: − 2.33; 95% CI: − 4.37, − 0.29) and combination therapy (SMD: 1.79 95% CI: 1.21, 2.41) were superior to western medicine. For serum CA125 level, acupoint application (SMD: − 11.33 95% CI: − 20.28, − 2.97) and combination therapy (SMD: 6.20; 95% CI: 1.60, 10.75) were associated with better efficacy when considered alongside western medicine. For response rate, combination therapy (SMD: 0.20; 95% CI: 0.14, 0.29) and auricular therapy (SMD: 8.01; 95% CI: 2.08, 45.37) were more efficacious than western medicine. The comprehensive ranking results show that acupoint catgut embedding was the best performing at lowering pain VAS scores, acupoint application was identified as the most effective in reducing serum CA125 level, and auricular therapy was ranked first in improving the response rate. Conclusion: Acupoint catgut embedding, auricular therapy, acupoint application and combination therapy may be the best solutions for the treatment of endometriosis. Additional trials are needed to develop higher-quality evidence and optimal regimens. Keywords: acupuncture, endometriosis, randomized controlled trials, network meta-analysis Endometriosis (EMs) is characterized by the endometrial tissue appears, grows, infiltrates, and bleeds repeatedly in the lining of the uterus and in areas outside of the uterus, subsequently causing pain, joint pain, infertility, and nodules. 1,2 Clinical manifestations include dysmenorrhea, pelvic pain, dyspareunia, and infertility. 3 It affects approximately 6% to 10% of women of childbearing age. 4 Epidemiological studies reveal that women with EMs have a higher risk of developing ovarian and breast cancer, melanoma, asthma, rheumatoid arthritis, and cardiovascular disease. 5 EMs seriously affects women's physical health, mental health and quality of life. 6 Therefore, effective interventions remain critical. Currently, the mainstay of drug therapy for EMs is hormone suppressive drugs. 7 In the context of endometriosis-related pain in patients with no current plans to become pregnant: combined oral contraceptives or progestins are low-cost drugs that should be considered as a first-line medical therapy. 8 Although medication is helpful, a large proportion of women (10.0–43.5%) discontinue drugs due to the presence of side effects, such as uterine bleeding, vomiting, breast discomfort, depression, weight gain, and moodiness. 9–12 As such, non-pharmacolog -Abstract Truncated-
clinical neurology